Pediatric Papillary and Follicular Thyroid Cancer: ATA Recommendations 25-34
Pediatric Management of Thyroid Nodules and Cancer: Summary of the American Thyroid Association’s Guideline
The following is a summary of recommendations from the American Thyroid Association Task Force on Pediatric Thyroid Cancer on the management of thyroid nodules and differentiated thyroid cancer in children. Part 5 of this series includes a summary of recommendations 25-34.
Data extracted from: Francis G, Waguespack SG, Bauer AJ, et al. Management guidelines for children with thyroid nodules and differentiated thyroid cancer: The American Thyroid Association Guidelines Task Force on Pediatric Thyroid Cancer. Thyroid. 2015 Apr 21. [Epub ahead of print].
Ratings: A, strongly recommends; B, recommends; C, recommends; D, recommends against; E, recommends against; F, strongly recommends against; I, recommends neither for nor against.
CT, computed tomography; FTC, follicular thyroid cancer; 131I, iodine-131; MRI, magnetic resonance imaging; PTC, papillary thyroid cancer; LT4, levothyroxine; Tg, thyroglobulin; TSH, thyroid stimulating hormone.
Access other summaries of the ATA's Pediatric Thyroid Cancer Guidelines:
- Pediatric Management of Thyroid Nodules and Cancer: Summary of the American Thyroid Association’s Guideline
- Recommendations 1-8
- Recommendations 9-16
- Recommendations 17-24
- Recommendations 25-34
July 14, 2015